ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 1278

$377K Total Retail Price of All Prescriptions

Rank: 247 out of 1278

476 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 4,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 384 289 1 2
SIMVASTATIN 381 281 2 3
LISINOPRIL 330 186 3 1
METFORMIN HCL 226 120 4 4
HYDROCODONE-ACETAMINOPHEN 208 116 S3 5 7
OMEPRAZOLE 207 134 6 6
HYDROCHLOROTHIAZIDE 202 115 7 8
LOVASTATIN 178 113 8 13
ATENOLOL 173 108 9 11
AMLODIPINE BESYLATE 143 118 10 5
FUROSEMIDE 131 69 11 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 70 12 30
GABAPENTIN 102 62 13 12
METOPROLOL TARTRATE 102 55 13 9
RANITIDINE HCL 101 53 15 20
CITALOPRAM HBR 100 49 16 22
FLUTICASONE PROPIONATE 88 42 17 24
ZOLPIDEM TARTRATE 81 65 18 16
OXYCODONE-ACETAMINOPHEN 77 41 S2 19 29
INSULIN SYRINGE 76 18 20 50
PRAVASTATIN SODIUM 74 55 21 14
OXYBUTYNIN CHLORIDE 73 34 22 80
GLIPIZIDE 73 42 22 35
IBUPROFEN 72 30 24 46
ALENDRONATE SODIUM 72 57 24 18
FLUOXETINE HCL 65 39 26 41
PROAIR HFA 64 16 27 26
DOXAZOSIN MESYLATE 63 32 28 69
TRAZODONE HCL 61 32 29 38
LOSARTAN POTASSIUM 61 47 29 19
CARISOPRODOL 58 12 R 31 51
ATORVASTATIN CALCIUM 58 52 31 15
SERTRALINE HCL 56 25 33 28
AMITRIPTYLINE HCL 55 17 R 34 55
PAROXETINE HCL 55 27 34 56
TRAMADOL HCL 55 39 34 25
CRESTOR 54 37 37 31
TAMSULOSIN HCL 50 50 38 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.